No. A comprehensive metabolic panel (CMP) does not include cholesterol. The CMP measures 14 blood analytes, and cholesterol is not one of them. Your total cholesterol, LDL, HDL, and triglycerides appear on a separate test called a lipid panel. Ordering a CMP to check cholesterol is a category error, and it happens often enough that clinicians field the question weekly.
What the CMP Actually Measures
A CMP is a fixed 14-test chemistry panel run on serum or plasma. It groups into five functional clusters: electrolytes, kidney markers, liver enzymes, glucose, and protein.
The electrolyte cluster covers sodium, potassium, chloride, and bicarbonate (reported as CO2). These numbers govern nerve conduction, muscle contraction, and acid-base balance. Sodium normally sits around 135 to 145 mmol/L, and potassium around 3.5 to 5.1 mmol/L. A potassium of 6.5 mmol/L is a cardiac emergency; a sodium of 120 mmol/L signals cerebral edema risk. Neither has any relationship to cholesterol.
The kidney cluster includes blood urea nitrogen (BUN) and creatinine, often paired with a calculated estimated glomerular filtration rate (eGFR). Creatinine rises when filtration falls, though it lags behind real injury by hours to days. The liver cluster includes alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, and total bilirubin. Glucose and the two proteins, albumin and total protein, round out the panel.
None of these analytes is a sterol. Cholesterol is a waxy lipid carried in lipoprotein particles, and it requires a dedicated enzymatic assay to quantify. The CMP's chemistry platform simply does not run that reaction.
Why Cholesterol Sits on a Different Panel
The separation is not arbitrary. It reflects assay chemistry, fasting requirements, and how clinicians calculate risk.
Cholesterol measurement relies on enzymatic colorimetric assays: cholesterol esterase cleaves esterified cholesterol, cholesterol oxidase generates hydrogen peroxide, and a peroxidase-linked dye reaction produces a signal proportional to concentration. Labs may report total cholesterol, HDL cholesterol, triglycerides, and a calculated LDL using the Friedewald equation or a newer direct method. Each of those steps is a separate reagent channel.
Lipid panels also historically require fasting for accurate triglycerides, though current guidance permits nonfasting testing for most risk screening (CDC). A CMP has no fasting dependency for most analytes, so bundling them would create ordering friction.
Then there is the risk math. Cardiovascular risk estimators such as the pooled cohort equations consume age, blood pressure, diabetes status, smoking, and lipid values together. Cholesterol lives inside that risk architecture, interpreted alongside the metabolic markers on the CMP rather than within it.
Plain-language version: the CMP checks your body's chemistry balance; the lipid panel checks your artery-clogging fat cargo. Different questions, different tubes.
CMP Versus Lipid Panel, Side by Side
| Feature | Comprehensive Metabolic Panel | Lipid Panel |
|---|---|---|
| Number of analytes | 14 | 4 (total cholesterol, LDL, HDL, triglycerides) |
| Cholesterol included | No | Yes |
| Fasting needed | Generally no | Usually no; fasting if triglycerides elevated |
| Primary purpose | Organ function and electrolytes | Cardiovascular risk |
| Typical result turnaround | Same day to 24 hours | Same day to 24 hours |
| Typical US cash price | USD 15 to 50 | USD 20 to 60 |
| Common add-on in wellness panels | Often bundled with CBC | Often bundled with CMP |
Direct-to-consumer lab pricing varies by vendor and region, so treat those figures as ranges rather than quotes.
Overlap and Edge Cases
Two CMP analytes cross-reference with lipid biology, and this is where the counterintuitive detail lives.
First, the CMP does not calculate non-HDL cholesterol or any atherogenic index. That calculation needs a total cholesterol value the panel never produces. Second, liver enzymes on the CMP (ALT and AST) can flag fatty liver disease, which correlates strongly with dyslipidemia. A clinician seeing an ALT of 55 U/L with a normal CMP may still order a lipid panel precisely because metabolic dysfunction and elevated LDL cluster together.
The reverse edge case matters too. A normal CMP does not rule out severe hypercholesterolemia. Familial hypercholesterolemia can produce LDL above 190 mg/dL with a perfectly unremarkable metabolic panel. The two tests occupy different diagnostic lanes, and normal results on one say nothing about the other.
Another trap: some lab requisitions label a combined order as a "comprehensive panel" when it is actually a CMP plus a lipid panel. Read the analyte list, not the order name.
Red Flags That Require Separate Testing
Total cholesterol at or above 240 mg/dL, or LDL at or above 160 mg/dL, warrants formal risk assessment. LDL at or above 190 mg/dL suggests possible familial hypercholesterolemia and merits evaluation. Triglycerides at or above 500 mg/dL carry pancreatitis risk and need prompt attention. A CMP showing glucose at or above 126 mg/dL on two occasions supports a diabetes evaluation, which itself changes lipid targets. Any abnormal liver enzyme on a CMP combined with dyslipidemia deserves a dedicated metabolic workup.
How to Actually Get Cholesterol Measured
Step one: request a lipid panel by name. Ask for total cholesterol, LDL, HDL, and triglycerides specifically. If a clinician orders "metabolic panel," clarify whether a lipid panel is also indicated.
Step two: know the thresholds you are working toward. Total cholesterol under 200 mg/dL is generally desirable, 200 to 239 mg/dL is borderline, and 240 mg/dL and above is high. LDL under 100 mg/dL is optimal for most adults, with lower targets for people with established cardiovascular disease. HDL at or above 40 mg/dL for men and 50 mg/dL for women is a common benchmark. These are population reference points, not individualized treatment goals; a clinician sets your target based on your full risk profile.
Step three: reconcile conflicting thresholds explicitly. Some labs flag LDL at 130 mg/dL as high while cardiology guidelines treat 100 mg/dL as the practical ceiling for elevated-risk patients. When your report uses one cutoff and your clinician uses another, the clinician's risk-based target governs.
Step four: repeat testing on a sensible schedule. Adults without risk factors typically screen every 4 to 6 years; people with diabetes, hypertension, or a family history screen more often, sometimes annually.
Step five: do not substitute. No combination of CMP analytes can reconstruct a cholesterol value. There is no formula, no proxy, and no workaround.
What This Means for Screening Programs
Population screening guidance treats the lipid panel as its own instrument, separate from metabolic chemistry. The US Preventive Services Task Force recommends lipid screening for adults at increased cardiovascular risk, and the exact interval depends on age and risk factors rather than on CMP results.
Health systems sometimes bundle a CMP and lipid panel into a single "basic health screen" order. That bundling is convenient, but it obscures the distinction. If you receive results showing only 14 analytes, cholesterol was not measured, regardless of what the order was called.
The limitation to state plainly: a CMP tells you about electrolytes, kidney filtration, liver injury, glucose, and protein status. It tells you nothing about your lipid cargo. If cholesterol is your question, the answer lives on a different requisition.
Quick Reference
| Analyte group | CMP includes | Lipid panel includes |
|---|---|---|
| Electrolytes | Yes (4 tests) | No |
| Kidney markers | Yes (BUN, creatinine, eGFR) | No |
| Liver enzymes | Yes (ALT, AST, ALP, bilirubin) | No |
| Glucose | Yes | No |
| Proteins | Yes (albumin, total protein) | No |
| Total cholesterol | No | Yes |
| LDL, HDL, triglycerides | No | Yes |
The keyword question has a one-line answer, and the rest of the panel's architecture explains why that answer will not change: the CMP and the lipid panel answer different physiological questions with different chemistry, and no amount of relabeling merges them.